Hyundai Pharmaceutical Co Ltd banner

Hyundai Pharmaceutical Co Ltd
KRX:004310

Watchlist Manager
Hyundai Pharmaceutical Co Ltd Logo
Hyundai Pharmaceutical Co Ltd
KRX:004310
Watchlist
Price: 13 110 KRW 0.08% Market Closed
Market Cap: ₩342.6B

Hyundai Pharmaceutical Co Ltd
Investor Relations

Hyundai Pharmaceutical Co., Ltd. engages in the manufacturing and distribution of pharmaceutical products, health food drinks and medical equipment. The company is headquartered in Cheonan, Chungcheongnam-Do and currently employs 378 full-time employees. The firm mainly provides two categories of products: pharmaceuticals, including ophthalmological tablets, clopidogrel bisulfate, mirtazapine tablets and others, which are applied in the treatment of depressive disorder, hypertension, hemostatics and others, as well as healthcare food products, including vitamin products, calcium supplements and others. The company also provides dietary various beverages and medical equipment. The firm mainly distributes its products within domestic market. In addition, the Company also involves in the leasing business.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Young-Hak Kim
President
No Bio Available

Contacts

Address
CHUNGCHEONGNAM-DO
Cheonan
55, Jandari-gil, Pungse-myeon, Dongnam-gu
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett